Title: RNAi Modulation of MLL-AF4 and Uses Thereof
Patent Number: 7,674,779
Filed: Feb. 27, 2008
Lead Inventor: Olaf Heidenreich, Alnylam Pharmaceuticals
"The invention relates to compositions and methods for modulating the expression of the MLL-AF4 fusion gene, and more particularly to the down-regulation of MLL-AF4, by chemically modified oligonucleotides," the patent's abstract states.